ventional brightfield light. This method allows detection of trophoblast cells within a mixed cell population and, at the same time, analysis of chromosome anomalies in the tcophoblast cells identified. For prenatal diagnosis of fetal cells enriched from maternal peripheral blood during pregnancy, this multiparameter in situ analysis of immobilized fetal trophoblast cells will be very useful. (JHistOchem Cytochem 43709-714, 1995)
We developed a non-radioactive assay for simultaneous detection of cytoplasmic mRNA and nudear genomic DNA in fetal trophoblast cells by sequential in situ hybridization. Trophoblast-specific mRNA is detected with a digoxigeninlabeled RNA probe complementary to HLA-G, followed by visualization through the generation of stable contrast-rich DABlNi complexes. Genomic target DNA is subsequently visualized in labeled cells by fluorescent in situ hybridization using biotin-labeled chromosome-specific DNA probes. Simultaneous visualization of both targets is made possible using a fluorescence microscope with FITC filter and con-
Yntroduction
During pregnancy, multiple types of fetal cells, i.e., trophoblasts, erythrocytes, and leukocytes, cross the placenta and circulate within the maternal blood (1). The presence of these fetal cells in the peripheral blood of pregnant women is of great clinical interest because these cells can be used for prenatal diagnosis of chromosomal anomalies (1,16,26 ). This could reduce the need for invasive methods, such as chorionic villous sampling or amniocentesis, both of which carry a risk for the fetus (2,15,20) .
In addition to the low frequency of fetal cells in the maternal blood during pregnancy, one of the main obstacles is the proper identification of fetal cells, whether of embryonic (nucleated red blood cells) or extraembryonic origin (trophoblasts). Some investigators used various monoclonal antibodies (MAbs) reactive with trophoblast cells (6,8,12,21,24), but not all of these MAbs have been made available. Moreover, some of the MAbs react with other cells in addition to trophoblasts, such as peripheral blood monocytes (21). Moreover, the absorption of fetal antigens by maternal blood cells is another source of false-positive reactions (1,3,6,11). To circumvent these problems, we have chosen to use HLA-G mRNA (14) as a target for identification of trophoblast cells by RNA in situ hybridization. Moreover, we extended this hybridization method for the simultaneous analysis of genomic target DNA in the labeled HLA-G mRNA-positive trophoblast cells by sequential in situ hybridization. The final method allows reliable multiparameter in situ analysis of immobilized trophoblast cells.
In this report we illustrate the use of this technique to identify HLA-G-expressing trophoblasts in a mixed cell population from first-trimester chorionic villous samplings. Because HLA-G mRNA is present exclusively in first-trimester (extra)villous trophoblast cells and placental villous mesenchymal cells (9,19,28), the presence of HLA-G permits identification of placental cells in these mixed cell populations. The method is likely to be a valuable tool for prenatal diagnosis of fetal aneuploidies in trophoblast cells enriched from maternal blood during pregnancy.
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Materials and Methods
Preparation of Cell Suspensions from Cborionic Villous Samples
Chorionic villous samples were obtained during pregnancy (Weeks 10-13) by transabdominal puncture under ultrasonographic guidance from pregnant women at risk for carrying a child with chromosomal anomalies because of advanced maternal age. The protocol was approved by the Committee of Medical Ethics of the Academic Hospital of the Free University Hospital, Amsterdam. Samples were obtained after informed consent. After extensive washing in HBSS (Hanks buffered saline solution; Gibco, Gaithersburg. MD). chorionic villous samples were incubated for 1 hr in 1 x trypsin-EDTA (0.5% trypsin, 0.2% EDTA; Gibco) at 3 7 T , followed by a 2-hr incubation in collagenase (1 mg/ml Type 11; Sigma, Bornem, Belgium) at 37°C. Cells were dispersed by passing the villi repeatedly through a syringe with a 0.6 x 30-mm gauge, followed by three washes in HBSS. Cells were fixed by adding 3 volumes of 4% formaldehyde in PBS, pH 7.5, and incubation for 90 min at room temperature (RT). Cells were washed twice in PBS and filtered through four layers of nylon mesh (pore size 0.25 mm) to eliminate large tissue fragments and cell clumps.
Preparation of the Shdes
Washed cell suspensions were allowed to settle on APES-coated microscope slides (3% 3-aminopropyltriethoxysilane in acetone) and air-dried at RT. Fixed and immobilized cells were passed through a graded series of ethanol and slides were stored dry at -20°C until further use.
RNA Probe Preparation
Digoxigenin-labeled (anti)sense RNA probes complementary to HLA-G mRNA were generated by promoter-mediated in vitro transcription of linearized pGEM4 plasmids (Promega; Madison WI) containing a 451 BP PvuII-PvuII gDNA fragment of the 3"xranslated region of the human HLA-6.0 gene (25,28). For this purpose, linearized plasmids (EcoRI or HindIII) were transcribed with either T7 or SP6 RNA polymerase according to Melton et al. (22) in the presence of digoxigenin-ll-UTP (Boehringer Mannheim; Mannheim, Germany). Ratios of UTP and digoxigenin-UTP were adjusted to generate equal labeling efficiencies (5%) and yields of both sense and anti-sense probes. Transcription was stopped by a 15-min incubation with RQ1 DNAse (1 U/& DNA) at 37°C. After ethanol precipitation, RNA probes were stored in aliquots at -70°C. Before use, digoxigenin-labeled HLA-G riboprobes were checked for size (510 bases including polylinker sequences), integrity, labeling efficiency, and quantity (10-15 pg). Serial dilutions were size-separated by gel electrophoresis (1.4% agarose) in the presence of formaldehyde, transferred to uncharged nylon membranes (Hybond-N; Amersham, 's Hertogenbosch, The Netherlands), and analyzed by chemiluminescence using immunodetection with sheep anti-digoxigenin Fab fragments labeled with alkaline phosphatase followed by chemiluminescence with AMPPD (Boehringer Mannheim).
DNA Probe Preparation
Biotinylated chromosome 1 centromere-specific DNA probes were made by nick-translation (Boehringer Mannheim) of pUC-1.77 plasmid DNA containing a 1.77 KB HindIII Satellite 111 repeat in pUC12 vector (10). After ethanol precipitation, DNA probes were dissolved at 20 ng/pI in TE.
In Situ Hybridization
RNA In Situ Hybridization. Slides with fixed cells were immersed for 10 min in methanol containing 0.3% Hz02 to block endogenous peroxidase. Cells were pre-digested for 30 min at 37'C in proteinase K (2.5 pglml). rinsed in PBS, and post-fixed in 0.4% paraformaldehyde in PBS, pH 7.2, for 20 min at 4°C. Slides were acetylated for 10 min in 0.1 M triethanolamine, pH 8.0, containing 0.25% acetic anhydride. After a short wash in 2 x SSC, pre-hybridization was performed for 120 min at S O T in hybridization mix (30 mM Tris, pH 7.6, 50 mM NaPi, 0.5% SDS, 50% formamide. 0.2% PVP, 0.2% Ficoll, 0.3 x SSC, human Cot1 DNA at 50 pglml). Afterpre-hybridization. slides were washed briefly in 2 x SSC, dehydrated, and hybridized overnight at 50°C (Tm-21) with similar amounts of sense or anti-sense digoxigenin-RNA probes (2-3 pg/ml.KB).
Before hybridization, probe and target were simultaneously denatured for 6-7 min at 70°C on a temperature-controlled hotplate (Shandon HP-100; Cheshire, UK). After hybridization, slides were washed twice for 15 min in 4 x SSC, digested with RNAse 1 (1 U/ml) (Promega) at 37°C for 30 min in 10 mM Tris. pH 7.5, 5 mM EDTA, 200 mM NaAc, and washed twice for 15 min each in 2 x SSC. Slides were washed in two changes of 0.1 x SSC for 15 min each at 60°C (Tm-15). Unspecific binding sites were blocked for 60 min at RT in 2 x SSC/O.O5% Triton X-100 containing 2% NHS, followed by two washes for 10 min each in 100 mM Tris, pH 7.4. 150 mM NaCl (TBS). Slides were subsequently incubated with sheep antidigoxigenin Fab fragments labeled with peroxidase (Boehringer Mannheim;
1:300 in 0.3% Triton X-100/1% NHS in TBS) for 180 min at 37'C. For detection, slides were incubated for 10 min in DAB/Ni/H202 (0.2 mg/ml diaminobenzidine. 0.06 p1 30% HzO~/ml in 50 mM Tris, pH 7.5, containing 0.7 mg/ml nickel chloride hexahydrate), washed in PBS twice for 5 min. and fixed in 4% paraformaldehyde, pH 7.6. Enhancement of DABlNi polymer complexes was done with silver nitrate at low pH in the presence of sodium tungstate and vitamin C according to Merchenthaler et al. (23) for 30-60 sec. Enhancement was repeated with fresh Merchenthaler solution if necessary, After washes in distilled water, slides were subjected to fluorescent DNA in situ hybridization.
DNA In Situ Hybridization. Before overnight hybridization, slides were incubated in 0.01% pepsin in 10 mM HCI at 37°C for 10 min, washed in PBS. and dehydrated. Hybridization mixtures (20 pl) containing 65% formamide/2 x SSC and 0.6 ng/pl pUC1.77-biotin were applied to dried slides, and slides were coverslipped, sealed, and denatured for 5 min at 80°C. Hybridization was performed overnight in a moist chamber at 37°C.
Slides were washed two times in 50% formamidel2 x SSC (10 min and 5 min) and twice in 2 x SSC at 43°C for 5 min each. Detection of biotinylated DNA hybrids was performed (20 min) with FITC-conjugated avidin (1:200; Vector, Burlingame, CA) after a IO-min incubation in 0.5% blocking reagent (Boehringer Mannheim) in 4 x SSC.
Microscopy
Cells were embedded in Vectashield (Vector) containing 0.25 pg/ml propidium iodide. Photomicrographs were made with an EPY 64T film (Kodak) on a Zeiss Axiophot microscope (Zeiss; Oberkochen, Germany) equipped with a 50-W mercury arc lamp. When cells were not processed for subsequent DNA in situ hybridization, cells were counterstained with nuclear fast red and embedded in DePeX (BDH; Poole, UK). The silverenhanced DAB/Ni complexes were viewed with conventional brightfield microscopy.
The nuclear fluorescence staining was viewed with an appropriate filter for F I E (450-490 nm). A combination of brightfield light and filters for fluorescence was used to visualize RNA and DNA signals simultaneously.
Resu It s
Fixed and immobilized cell suspensions obtained from first-trimester (Weeks 10-13) chorionic villous samples were used as a model system to establish a multiparameter in situ analysis method of immobilized trophoblast cells by combined non-radioactive DNA and RNA in situ hybridization.
The cellular distribution of HLA-G mRNA was analyzed by RNA in situ hybridization using digoxigenin-labeled RNA probes. Before use, digoxigenin-labeled HLA-G riboprobes generated by promotor-mediated in vitro transcription with T7 or SP6 RNA polymerase were checked for size, integrity, quantity, and labeling efficiency by chemiluminescence analysis of size-separated probes immobilized on nylon membranes (Figure 1) . Only high-quality probes, i.e., intact and of uniform length with no evidence of extraneous or degraded transcripts, were considered for in situ hybridization. The amounts of anti-sense and control sense probe used were calculated by densitometric analysis (Cybertech CSI densitometric system) as described previously for biotin-labeled RNA probes (5). Amounts of sense or anti-sense probes were corrected if necessary to ensure that equal concentrations (2-3 pg/ml.KB) were applied during hybridization. The probe used is complementary to the 3'-untranslated region of HLA-G mRNA and permits specific analysis of HLA-G under high-stringency conditions (Tm-15/-21) with no crossreaction to other known MHC Class I genes (25,28). Hybridization of early placental bed sections (data not shown) showed hybridization to trophoblast cells only, with no crosshybridization to maternal cells. Moreover, the probe used should hybridize to all four presently identified alternative transcripts of HLA-G (17,18), since these transcripts all contain identical 3' UTR sequences. Specific black cytoplasmic signals representing HLA-G mRNA. which can be visualized by conventional brightfield light microscopy, were present in about 60-70% of the cells (Figure 2A ). This percentage is in the range of what would be expected according to the percentage of different cell types present in cell suspensions from chorionic villous samplings (7). The majority of cytotrophoblast cells and villous mesenchymal cells are HLA-G-expressing cells. Other cells, such as contaminating blood cells, fibroblasts, and syncytiotrophoblasts, are HLA-G-negative (9,28). Different fixation procedures, including acetone, methanol, and paraformaldehyde, were tested. Immediate fixation (within 20 min) in buffered formaldehyde, followed by mild proteolytic pre-treatment with proteinase K (2.5 pg/ml), proved optimal and was compatible with subsequent fluorescent DNA in situ hybridization. Control hybridizations with sense RNA probes were completely negative ( Figure 2B ). The use of human Cot1 DNA proved essential and superior, compared to salmon testis DNA, for highest specificity and optimal signal-noise ratios.
After RNA hybridization, slides were processed for simultaneous analysis of genomic DNA by fluorescent in situ hybridization with biotinylated DNA probes. Pre-treatment for DNA hybridizations that have already undergone RNA hybridization is limited to an additional proteolytic treatment of the slides. All other subsequent steps essential for DNA hybridization and detection remain unchanged compared to conventional DNA in situ hybridization. The well-characterized chromosome 1 centromere-specific repeat probe pUC-1.77 was used for this DNA in situ hybridization. Two discrete chromosome 1 signals could be seen in the majority (>95%) of the nuclei ( Figure 3A ).
When these same cells were viewed with simultaneous fluorescent light and brightfield light microscopy, both the mRNA and DNA signal could be observed ( Figure 3B ). Among the cells shown, HLA-G-positive as well as HLA-G-negative cells are present.
Discussion
We describe here a protocol that permits sequential RNA and DNA in situ hybridization on immobilized trophoblast cells from chorionic villous samplings. Trophoblast cells are a source of fetal DNA and therefore, like nucleated fetal erythrocytes, are potentially usdul for non-invasive prenatal diagnosis. However, because fetal cells are very rare in the maternal circulation, an enrichment step is required. Different methods have been described, including FACS, MACS, density gradients, or a combination of these techniques (4,8,13.29). In none of these studies, however, could a complete elimination of the maternal contaminating cells be achieved. Therefore, one of the major problems in the use of fetal cells from peripheral blood for prenatal diagnosis remains the reliable identification of these cells. A method is required that distinguishes fetal cells from maternal cells and permits simultaneous analysis of genomic DNA. The combined in situ hybridization method described here fulfills these criteria. Our data indicate that this technique can be very useful for non-invasive prenatal diagnosis of numerical chromosomal aber-1 2 3 4 5 6 -600 -400 -300 expressed (27,28) , or is expressed at very low levels (la), in adult blood cells. Our preliminary results show no detectable HLA-G mRNA staining in adult blood cell populations (not shown). The detection of the RNA hybrid with the stable DAB/nickel/silver complex allows subsequent DNA fluorescent hybridization without loss of the mRNA signal. Moreover, silver enhancement of the DAB/Ni complex permits careful control of the staining reaction to compensate for variations in hybridization and detection efficiency before subsequent DNA hybridization. This leaves the nuclei in the majority of the HLA-G-expressing cells free of silver deposits and thus allows reliable interpretation of genomic FISH signals. In conclusion, this non-radioactive double staining protocol permits rapid specific and sensitive analysis of aneuploidy in fetal cells, which makes it suitable for diagnostic purposes.
We are presently investigating different procedures to enrich fetal trophoblast cells from matemal blood (van Wijk et al., manuscript in preparation). The combined in situ method described here will then allow identification, quantitation, and characterization of the isolated cells and thereby provide a means to develop a new non-invasive, rapid, and reliable method for prenatal diagnosis. Moreover, we believe that the method described here will be useful for a wide range of other applications in which multiparameter in situ analysis of DNA and RNA in specific target cells is required.
